TOBRAMYCIN
THERAPY
OF
INFECTIONS
DUE
TO
PSEUDOMONAS
AERUGINOSA
IN
PATIENTS
WITH
CYSTIC
FIBROSIS
EFFECT
OF
DOSAGE
AND
CONCENTRATION
OF
ANTIBIOTIC
IN
SPUTUM
ESTABLISHED
RESPIRATORY
INFECTIONS
WITH
MUCOID
PSEUDOMONAS
AERUGINOSA
IN
PATIENTS
SUFFERING
FROM
CYSTIC
FIBROSIS
WERE
TREATED
WITH
CONVENTIONAL
AS
WELL
AS
LARGER
DOSES
OF
TOBRAMYCIN
THE
INFECTION
WAS
ERADICATED
IN
FOUR
OF
THE
17
PATIENTS
TREATED
BUT
THE
DURATION
OF
FOLLOWUP
STUDY
OF
ONE
PATIENT
WAS
SHORT
IT
APPEARED
THAT
TREATMENT
WAS
MOST
SUCCESSFUL
IN
THOSE
PATIENTS
IN
WHOM
THE
HIGHEST
PEAK
CONCENTRATIONS
OF
TOBRAMYCIN
IN
SPUTUM
WERE
OBTAINED
NO
SIDE
EFFECTS
WERE
NOTED
EVEN
WHEN
TOBRAMYCIN
WAS
GIVEN
IN
LARGE
DOSES
FOR
TWO
WEEKS
